logo
Plus   Neg
Share
Email

Merck Announces Label Expansion For KEYTRUDA In Canada - Quick Facts

Merck (MRK) announced that Health Canada has expanded the label for KEYTRUDA (pembrolizumab), the company's anti-PD-1 therapy, to include approval for the treatment of metastatic non-squamous non-small cell lung cancer or NSCLC, in combination with pemetrexed and platinum chemotherapy, in adults with no EGFR or ALK genomic tumour aberrations, and no prior systemic chemotherapy treatment for metastatic NSCLC.

KEYTRUDA was first approved in Canada in 2015 and currently has eight indications in a number of disease areas, including non-small cell lung cancer, classical Hodgkin lymphoma, melanoma and bladder cancer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google announced a new $600 million investment for the expansion of Mayes County data center. The tech giant had started the data center in 2007 and expanded three times already. The new investment will add 100 jobs to Pryor community, Google CEO Sundar Pichai said during the announcement. In... King Arthur Flour, Inc. voluntarily recalled certain lots of 5 lb. Unbleached All-Purpose Flour due to the potential presence of Escherichia coli bacteria (E. coli), The U.S. Food and Drug Administration (FDA) stated. The company announced it is recalling 14,218 cases of the potentially affected lots that were distributed through retailers and distributors nationwide. Burger King has launched a new Upside Down Whopper in celebration of the third season of Netflix series "Stranger Things." The hamburger chain, in partnership with Netflix, announced it will start selling an Upside Down Whopper sandwich, which is just a regular Whopper served upside down, from June...
Follow RTT